WDGBANDTI:一种基于深度图的卷积网络的双线注意网络,用于预测药物向相互作用与域调整
Nianrui Wang1, Shumin Zhao1, Ziwei Li1
1School of Mathematics and Physics, China University of Geosciences, Wuhan, 430074, China.
概括
本研究介绍了WDGBANDTI,这是一个可解释的深度学习框架,用于药物向相互作用分析. 该模型通过识别关键子结构并提高预测准确性来增强药物开发.
科学领域:
- 生物医学信息学 生物医学信息学
- 计算化学的计算化学
- 药物发现 药物发现 药物发现
背景情况:
- 药物开发需要评估有效性和了解副作用机制.
- 深度学习是分析药物向相互作用的热点,但面临着可解释性和原子级分析挑战.
- 现有的方法很难将生物医学见解与深度学习相结合,以提高医疗健全性.
研究的目的:
- 开发一种可解释的深度学习框架,用于药物向相互作用分析.
- 解决当前深度学习模型中原子级分析和生物医学集成的局限性.
- 提高在亚结构层面对药物向相互作用的预测.
主要方法:
- 构建了WDGBANDTI,这是一个可解释的深度学习框架,使用深度图形卷积网络 (Deep-GCN) 和双线注意网络 (BAN).
- 在亚结构层面分析和预测药物向相互作用.
- 集成的模块来增强对未识别的目标配对的预测能力.
主要成果:
- 在多个数据集上验证了WDGBANDTI,与最先进的方法相比,显示出更高的准确性,灵敏性和特异性.
- 双线注意网络 (BAN) 组件成功识别了涉及药物向相互作用的关键子结构,展示了模型的可解释性.
- 实现了药物向相互作用的增强预测能力.
结论:
- WDGBANDTI有助于推进药物开发和副作用研究.
- 该框架为合理的药物设计提供了有意义的指导.
- 强调了可解释的深度学习在制药研究中的潜力.
相关概念视频
01:25Drug-Receptor Interaction: Agonist
4.0K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.0K
01:28Drug-Receptor Interaction: Antagonist
4.9K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
4.9K
01:30Quantitative Aspects of Drug-Receptor Interaction
1.7K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.7K
01:29Drug-Receptor Interactions
7.3K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.3K
01:15Drug Concentration Versus Time Correlation
2.0K
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
2.0K
01:26Targets for Drug Action: Overview
10.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.1K